This application note describes the extraction of Δ9-THC (tetrahydrocannabinol), 11-hydroxy- Δ9-THC and 11-nor-9-carboxy-THC from whole blood matrix, prior to GC/MS analysis. An extremely simple sample pre-treatment and extraction method is employed to extract the parent THC and main metabolites from complex whole blood matrix, delivering high, reproducible analyte recoveries. The optimized SLE+ protocol demonstrated analyte recoveries ranging from 72-83%. RSD’s were below 10% for all analytes.
In the Eyes of a Forensic Chemist - Interview with Professor Sabra Botch-Jones
Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications
New Ultra Convenient Solid Phase Extraction Disks from Biotage
Hydrolyze Urine Samples In-Situ - New Application Note
DryVap® Inline Concentration System